152 related articles for article (PubMed ID: 18006097)
1. Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?
Folkvord S; Flatmark K; Seierstad T; Røe K; Rasmussen H; Ree AH
Radiother Oncol; 2008 Mar; 86(3):428-34. PubMed ID: 18006097
[TBL] [Abstract][Full Text] [Related]
2. Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines.
Atallah D; Marsaud V; Radanyi C; Kornprobst M; Rouzier R; Elias D; Renoir JM
Int J Hyperthermia; 2004 Jun; 20(4):405-19. PubMed ID: 15204521
[TBL] [Abstract][Full Text] [Related]
3. In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line.
Kjellström J; Kjellén E; Johnsson A
Acta Oncol; 2005; 44(7):687-93. PubMed ID: 16227158
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin exerts potent in vitro cytotoxicity in colorectal and pancreatic cancer cell lines and liver metastases.
Kornmann M; Fakler H; Butzer U; Beger HG; Link KH
Anticancer Res; 2000; 20(5A):3259-64. PubMed ID: 11062751
[TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin resistance induced by ERCC1 up-regulation is abrogated by siRNA-mediated gene silencing in human colorectal cancer cells.
Seetharam RN; Sood A; Basu-Mallick A; Augenlicht LH; Mariadason JM; Goel S
Anticancer Res; 2010 Jul; 30(7):2531-8. PubMed ID: 20682979
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin activity in selected and unselected human ovarian and colorectal cancer cell lines.
Noordhuis P; Laan AC; van de Born K; Losekoot N; Kathmann I; Peters GJ
Biochem Pharmacol; 2008 Jul; 76(1):53-61. PubMed ID: 18508032
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib and radiation: a promising combination in colorectal cancer.
Suen AW; Galoforo S; Marples B; McGonagle M; Downing L; Martinez AA; Robertson JM; Wilson GD
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):213-20. PubMed ID: 20708486
[TBL] [Abstract][Full Text] [Related]
8. Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status.
Folkvord S; Ree AH; Furre T; Halvorsen T; Flatmark K
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):546-52. PubMed ID: 19427556
[TBL] [Abstract][Full Text] [Related]
9. Chemo-radio-gene therapy for colorectal cancer cells using Escherichia coli uracil phosphoribosyltransferase gene.
Koyama F; Fujii H; Mukogawa T; Ueno M; Hamada H; Ishikawa H; Doi S; Nakao T; Matsumoto H; Shimatani H; Takeuchi T; Nakajima Y
Anticancer Res; 2003; 23(2B):1343-8. PubMed ID: 12820392
[TBL] [Abstract][Full Text] [Related]
10. Combining radiation with oxaliplatin: a review of experimental results.
Hermann RM; Rave-Fränk M; Pradier O
Cancer Radiother; 2008 Jan; 12(1):61-7. PubMed ID: 18243751
[TBL] [Abstract][Full Text] [Related]
11. In vitro schedule-dependent interaction between paclitaxel and oxaliplatin in human cancer cell lines.
Tanaka R; Ariyama H; Qin B; Takii Y; Baba E; Mitsugi K; Harada M; Nakano S
Cancer Chemother Pharmacol; 2005 Jun; 55(6):595-601. PubMed ID: 15731917
[TBL] [Abstract][Full Text] [Related]
12. The optimal schedule for 5-fluorouracil radiosensitization in colon cancer cell lines.
Ojima E; Inoue Y; Watanabe H; Hiro J; Toiyama Y; Miki C; Kusunoki M
Oncol Rep; 2006 Nov; 16(5):1085-91. PubMed ID: 17016597
[TBL] [Abstract][Full Text] [Related]
13. Opposing securin and p53 protein expression in the oxaliplatin-induced cytotoxicity of human colorectal cancer cells.
Chiu SJ; Hsu TS; Chao JI
Toxicol Lett; 2006 Dec; 167(2):122-30. PubMed ID: 17045763
[TBL] [Abstract][Full Text] [Related]
14. Synergistic antitumour effect of raltitrexed and 5-fluorouracil plus folinic acid combination in human cancer cells.
Avallone A; Di Gennaro E; Bruzzese F; Laus G; Delrio P; Caraglia M; Pepe S; Comella P; Budillon A
Anticancer Drugs; 2007 Aug; 18(7):781-91. PubMed ID: 17581300
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle arrest and apoptosis induced by oxaliplatin (L-OHP) on four human cancer cell lines.
William-Faltaos S; Rouillard D; Lechat P; Bastian G
Anticancer Res; 2006; 26(3A):2093-9. PubMed ID: 16827150
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle arrest by oxaliplatin on cancer cells.
William-Faltaos S; Rouillard D; Lechat P; Bastian G
Fundam Clin Pharmacol; 2007 Apr; 21(2):165-72. PubMed ID: 17391289
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicity.
Meynard D; Le Morvan V; Bonnet J; Robert J
Oncol Rep; 2007 May; 17(5):1213-21. PubMed ID: 17390068
[TBL] [Abstract][Full Text] [Related]
18. Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells.
Spagnoletti G; Li Bergolis V; Piscazzi A; Giannelli F; Condelli V; Sisinni L; Bove G; Storto G; Landriscina M
Tumour Biol; 2018 Apr; 40(4):1010428318770957. PubMed ID: 29663854
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
[TBL] [Abstract][Full Text] [Related]
20. Combination effects of SC144 and cytotoxic anticancer agents.
Oshima T; Cao X; Grande F; Yamada R; Garofalo A; Louie S; Neamati N
Anticancer Drugs; 2009 Jun; 20(5):312-20. PubMed ID: 19322070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]